Profound Medical Corp expected to post a loss of 35 cents a share - Earnings Preview

Profound Medical

04/03/2025 21:37

Profound Medical Corp PRN.TO  is expected to show a rise in quarterly revenue when it reports  results on March 6 for the period ending December 31 2024

The Mississauga Ontario-based  company is expected to report a 112.4% increase in revenue to $4.267 million from $2.01 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Profound Medical Corp is for a loss of 35 cents per share.

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Profound Medical Corp is C$24.42​, above​ its last closing price of C$10.11. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.29
-0.29
-0.38
Missed
-29.9
Jun. 30 2024
-0.29
-0.29
-0.28
Beat
4.1
Mar. 31 2024
-0.28
-0.27
-0.26
Beat
5.5​
Dec. 31 2023
-0.28
-0.32
-0.42
Missed
-31.5
​​Sep. 30 2023
-0.33
-0.34
-0.26
Beat
22.7
Jun. 30 2023
-0.36
-0.35
-0.35
Met
1.4​
Mar. 31 2023
-0.35
-0.36
-0.32
Beat
11.1
Dec. 31 2022
-0.37
-0.46
Missed
-24.3

This summary was machine generated March 4 at 21:37 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)